June 12, 2020 / 11:18 AM / a month ago

BRIEF-Keros Therapeutics Presents Results From Clinical And Preclinical Studies Investigating KER-050

June 12 (Reuters) - Keros Therapeutics Inc:

* KEROS THERAPEUTICS PRESENTS RESULTS FROM CLINICAL AND PRECLINICAL STUDIES INVESTIGATING KER-050, ALONG WITH PRECLINICAL DATA FROM ITS ALK2 INHIBITOR PROGRAM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below